FiO2 Delivered by Nasal Cannula

Oxygen Delivery via Nasal Cannula: Key Principles

• A 5L nasal cannula delivers approximately 40% FiO2, though this can vary significantly between patients based on their breathing pattern and other physiological factors 1, 2
• 1-4 L/min delivers approximately 24-40% FiO2, equivalent to Venturi masks at these concentrations 1, 3
• 5 L/min delivers approximately 40% FiO2 2
• 1-6 L/min provides an FiO2 range from approximately 24% to 50%, making nasal cannulae suitable for variable oxygen therapy 2

Clinical Applications and Considerations

• Nasal cannulae offer better patient comfort compared to masks 2
• Nasal cannulae can be worn during meals and speech 2
• Nasal cannulae are less likely to be removed by patients 2
• Nasal cannulae have less inspiratory resistance than face masks 2
• Nasal cannulae have no risk of carbon dioxide rebreathing 2
• Nasal cannulae are more cost-effective than other oxygen delivery systems 2
• The actual FiO2 cannot be precisely predicted, making it unsuitable when exact FiO2 calculation is required (e.g., for A-a gradient determination) 1, 2
• Nasal cannulae may cause nasal irritation or soreness, especially at higher flow rates 2
• Nasal cannulae may not be effective if the patient has severe nasal congestion 2
• Flow rates above 4 L/min can cause discomfort and nasal dryness in some patients, though many tolerate it well 1

Clinical Decision Making

• For patients requiring medium-concentration oxygen therapy, nasal cannulae are preferred over simple face masks 4
• For patients requiring precise FiO2 control (particularly those at risk of hypercapnic respiratory failure), Venturi masks may be more appropriate 4
• For many patients, 24-28% Venturi masks can be substituted with nasal cannulae at 1-2 L/min to achieve the same target range 4
• Adjust flow rates based on oximetry measurements and, when necessary, blood gas results 1

High-Flow Nasal Cannula Therapy

• High-flow nasal cannula (HFNC) systems can deliver flows of 60 L/min or more with more predictable FiO2 2
• HFNC provides additional benefits including CPAP effect and improved patient comfort 5
• HFNC may reduce intubation rates in patients with acute hypoxemic respiratory failure 5

Oxygen Delivery via Nasal Cannula

Standard (Low-Flow) Nasal Cannula

• The maximum flow rate for standard nasal cannula is 6 L/min, which delivers approximately 24-50% FiO2 depending on the patient's breathing pattern, as recommended by the National Comprehensive Cancer Network 6
• The British Thoracic Society specifically recommends supplemental oxygen by nasal cannulae at 2-6 L/min when used alongside air-driven nebulizers for patients requiring controlled oxygen therapy 7

High-Flow Nasal Cannula (HFNC)

• The American Thoracic Society implies that high-flow nasal cannula systems can provide warmed, humidified oxygen with more predictable FiO2 delivery at flow rates of 60-70 L/min or higher, although this is not directly stated in the provided citations, the difference in flow rate capability is noted 6

Clinical Decision Algorithm

• For patients requiring medium-concentration oxygen therapy, the British Thoracic Society recommends using standard nasal cannula, which can deliver 24-50% FiO2 7
• For patients at risk of hypercapnic respiratory failure, the British Thoracic Society recommends targeting lower oxygen saturations (88-92%) regardless of delivery method 7

Oxygen Delivery Through Nasal Cannula

Flow Rate Ranges and FiO2 Delivery

• The American Thoracic Society recommends that standard nasal cannula delivers oxygen at flow rates of 1-6 L/min, providing approximately 24-50% FiO2, with the actual concentration varying significantly based on individual breathing patterns 8, 9
• Flow rates of 1-4 L/min deliver approximately 24-40% FiO2, roughly equivalent to Venturi masks at these concentrations 8, 9, 10
• Oxygen concentration continues to rise at flows above 6 L/min, though patient tolerance becomes more variable 8, 9

Critical Clinical Considerations

• The actual FiO2 delivered cannot be precisely predicted because it varies widely based on individual breathing patterns, respiratory rate, and whether the patient breathes through their mouth or nose 8, 9, 10
• Mouth breathing actually results in the same or higher inspired oxygen concentration, especially when respiratory rate is increased 8, 9

Patient Tolerance and Comfort

• Greater patient comfort and preference is noted with nasal cannula compared to face masks 9
• No claustrophobic sensation is experienced with nasal cannula 9
• No risk of carbon dioxide rebreathing is present with nasal cannula 9

Clinical Decision Algorithm

• Adjust flow rates based on oximetry measurements and, when necessary, blood gas results 8, 9
• Individual variation in breathing pattern requires individualized titration rather than relying on fixed FiO2 estimates 8, 9, 10

Common Pitfalls to Avoid

• Never assume a specific flow rate delivers a precise FiO2 – the same flow rate can have widely different effects on blood oxygen levels in different patients 8, 9, 10
• Don't assume nasal cannulae are ineffective in mouth breathers – mouth breathing often increases delivered oxygen concentration 8, 9

Oxygen Delivery via Nasal Cannula in Patients at Risk of Hypercapnic Respiratory Failure

Risk of Oxygen‑Induced Hypercapnia

• In individuals prone to hypercapnic respiratory failure, delivering oxygen at 6 L/min via a standard nasal cannula can cause excessive oxygenation and precipitate hypercapnia within approximately 15 minutes. 11

Target Oxygen Saturation

• For these patients, the recommended oxygen saturation target is 88 %–92 % rather than attempting to normalize arterial oxygen levels. 11

Preferred Flow Rates and Delivery Devices

• A lower flow rate of 2 L/min–4 L/min, or the use of a Venturi mask, is advised to achieve more controlled and precise FiO₂ delivery in this population. 11

Maximum Duration of High‑Flow Oxygen When Precise Control Is Unavailable

• When precise FiO₂ control cannot be ensured, exposure to high‑flow oxygen should be limited to a maximum of 6 minutes in acute care settings. 11